Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Nautilus Biotechnology, Inc. (NAUT : NSDQ)

• Company Description    Nautilus Biotechnology Inc. is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus Biotechnology Inc., formerly known as Arya Sciences Acquisition Corp III, is based in SEATTLE. Number of Employees: 113

• Price / Volume Information    Yesterday's Closing Price: $3.85 Daily Weekly Monthly 20 Day Moving Average: 283,612 shares Shares Outstanding: 124.46 (millions) Market Capitalization: $479.18 (millions) Beta: 52 Week High: $11.69 52 Week Low: $3.13 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.53% 9.77% 12 Week -0.26% 9.64% Year To Date -25.68% -9.19%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2701 EASTLAKE AVENUE EAST SEATTLE - SEATTLE,WA 98102 USA ph: 206-333-2001 fax: - investorrelations@nautilus.bio http://www.nautilus.bio

• General Corporate Information    Officers Sujal Patel - Chief Executive Officer; President and Director Anna Mowry - Chief Financial Officer Michael Altman - Director Melissa Epperly - Director Parag Mallick - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 63909J108 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/09/22 Share - Related Items Shares Outstanding: 124.46 Most Recent Split Date: (:1) Beta: Market Capitalization: $479.18 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.17 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.66 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/09/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.37 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - -15.57 12/31/21 - -17.71 09/30/21 - - ROA 03/31/22 - -14.77 12/31/21 - -15.16 09/30/21 - - Current Ratio 03/31/22 - 51.06 12/31/21 - 60.09 09/30/21 - 83.68 Quick Ratio 03/31/22 - 51.06 12/31/21 - 60.09 09/30/21 - 83.68 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - 2.81 12/31/21 - 2.93 09/30/21 - 3.04 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©